Letco’s Leadership Management Team (LMT) consists of four talented pharmaceutical industry veterans, each with a specific role in leading the Company. The LMT is unique in that they have worked together for many years at multiple companies; three have spent more than 15 years as colleagues. This has resulted in the development of an extremely cohesive and collaborative team who understands and leverages each other’s strengths. They were all investors and key members of the management team that transformed The Harvard Drug Group from a generic supplier that had its DEA license suspended in 2010 to a thriving, reputable business purchased by Cardinal Health in 2015.
On July 2, 2018, the LMT became the sole owners of Letco. The decision to purchase the business was deeply rooted in their high degree of confidence in the future of compounding, Letco’s associates, and in the critical services you provide your patients, day in and day out.
As Letco’s owners and full-time operators, the LMT devotes their efforts towards building something unique for compounding pharmacies that does not exist in the marketplace today. This superb and dedicated team is passionate about the business and committed to its long-term success. Watch this quick video to learn more about the team changing the face of the compounding industry.
Doug Bowman, Chief Executive Officer:
Since his appointment as CEO in 2016, Doug has developed a large scale, long term business investment strategy to better align Letco’s offerings to compounding pharmacies’ current and emerging needs. Doug led the continued expansion of Letco's robust product quality assurance programs, providing unparalleled integrity and product quality to Letco customers. Doug served as a Strategic Advisor to Letco and Court Square Capital Investments for more than a year before joining the company as CEO. Prior roles include COO of The Harvard Drug Group (THDG) until Cardinal Health acquired the company in 2015. Preceding THDG, Doug spent almost ten years serving in a variety of progressively responsible positions at AmerisourceBergen, including Vice President of Business Transformation; before entering the wholesale drug industry, Doug held senior-level positions at both CapGemini Ernst & Young and Wolters Kluwer. Doug is a graduate of Lake Forest College with a Bachelor of Arts in Political Science and holds a Master of Business Administration from The Pennsylvania State University.
Todd Way, Chief Financial Officer:
Letco’s CFO since 2013, Todd led all IT efforts required to establish Letco as a stand-alone business after it separated from The Harvard Drug Group (THDG), and now leads Letco’s new web strategy and roll-out of a best-in-class e-commerce platform to better serve customers. Todd joined THDG as VP Financial Planning & Analysis in 2012 and was promoted to CFO in 2013. Before joining THDG, Todd worked at AmerisourceBergen (ABC) as Corporate VP of Financial Planning and Analysis and led the Record to Report process team during ABC’s SAP implementation. Before ABC, Todd spent eight years in public accounting with various Northeast region firms. Todd holds a Bachelor of Science from Rutgers University and is a licensed Certified Public Accountant.
Greg Lake, Chief Sales & Marketing Officer:
Greg joined Letco Medical as CSMO in 2016 and since that time, has transformed the salesforce and marketing teams while expanding capacity by 30% to better serve customers. Externally, Greg led an industry-wide rebranding program to better articulate Letco’s market position and capabilities. Greg served as a Strategic Advisor to Letco and Court Square Capital Investments before joining the Company. Greg was previously Senior Executive VP of Sales & Marketing for The Harvard Drug Group (THDG) where he had responsibility for all sales and marketing activities within THDG’s distribution businesses. Greg began his sales career as an inside sales representative before finding his niche in sales management in roles such as Vice President of Sales at TruGreen and DeerTech as well as President of DeerTech. Greg earned his Bachelor of Arts in Organizational Communications from Ohio State University.
Steve Bencetic, Chief Administrative Officer:
Steve joined Letco as Chief Administrative Officer in 2016 and led the overall program to carve-out Letco as a stand-alone entity from The Harvard Drug Group (THDG). Those activities wrapped up in Q1 2017, and his focus shifted to the design and implementation of a market pricing program that allows for customer-specific pricing on each item in Letco’s inventory. Steve served as a Strategic Advisor to Letco and Court Square Capital Investments for more than a year before formally joining the Company. His prior roles include CAO of THDG from 2010 through 2015, as well as increasingly responsible positions at AmerisourceBergen (ABC) including Vice President of Strategic Integration and Executive Director of Operations Integration. Before joining ABC, Steve was with CapGemini Ernst & Young in a Senior Manager position. Steve holds a Bachelor of Business Administration in Finance from St. Bonaventure University and a Master of Business Administration from The Pennsylvania State University.